Interferon-γ regulates apoptosis by releasing soluble tumor necrosis factor receptors in a gastric epithelial cell line

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 12, 2002, Pages 1283-1290

  Furuta, Shimako ^a   Goto, Hidemi ^a   Niwa, Yasumasa ^a   Ohmiya, Naoki ^a   Kamiya, Kenji ^a   Oguri, Akihiko ^a   Hayakawa, Tetsuo ^a   Mori, Naoyoshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Helicobacter pylori; Interferon ; Phenylmethylsulfonyl fluoride; Soluble tumor necrosis factor receptors; Tumor necrosis factor

Indexed keywords

BENZYLSULFONYL FLUORIDE; GAMMA INTERFERON; SERINE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EPITHELIUM;

EID: 0036435889     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02893.x     Document Type: Article

References (37)

1. Wang MW, Creasey AA, Ladner MB et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985; 228: 149-54.
2. Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature 1985; 313: 803-6.
3. Gray PW, Aggarwal BB, Benton CV, et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.Nature 1984; 312: 721-4.
4. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-9.
5. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R. Characterization of binding biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 1990; 171: 415-26.
6. Kruppa G, Thoma B, Machleidt T, Wiegmann K, Kronke M. Inhibition of tumor necrosis factor (TNF)-mediated NF-KB activation by selective blockade of the human 55-kDa TNF receptor. J. Immunol. 1992; 148: 3152-7.
7. Schall TJ, Lewis M, Koller KJ et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990; 61: 361-70.
8. Loetscher H, Pan YE, Lahm H, et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990; 61: 351-9.
9. Nophar Y, Kamper O, Brakebusch C et al. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and soluble form of the receptor. EMBO J. 1990; 9: 3269-78.
10. Heaney ML, Golde DW. Soluble hormone receptors. Blood 1993; 82: 1945-8.
11. Mohler KM, Torrance DS, Smith CA et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonist. J. Immunol. 1993; 151: 1548-61.
12. Seckinger P, Isaaz S, Dayer JM. A human inhibitor of tumor necrosis factor α. J. Exp. Med. 1988; 167: 1511-16.
13. Olsson I, Lantz M, Nilsson E, et al. Isolation and characterization of tumor necrosis factor binding protein from urine. Eur. J. Haematol. 1989; 42: 270-5.
14. Aderka D, Engelmann H, Hornik V, et al. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 1991; 51: 5602-7.
15. Hwang C, Gatanaga M, Granger GA, Gatanaga T. Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vivo. J. Immunol. 1993; 151: 5631-8.
16. Mohler KM, Sleath PR, Fitzner JN et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 1994; 370: 218-20.
17. Gearing AJH, Beckett P, Christodoulou M et al. Processing of tumour necrosis factor-α precursor by metallopro-teinases.Nature 1994; 370: 555-7.
18. McGeeham GM, Becherer JD, Bast RC, et al. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 1994; 370: 558-61.
19. Bjornberg F, Lantz M, Gullberg U. Metalloproteases and serine proteases are involved in the cleavage of the two tumour necrosis factor (TNF) receptors to soluble forms in the myeloid cell lines U-937 and THP-1. Scand. J. Immunol. 1995; 42: 418-24.
20. Vey E, Burger D, Dayer JM. Expression and cleavage of tumor necrosis factor-α and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.Eur. J. Immunol. 1996; 26: 2404-9.
21. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumor necrosis factor a and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
22. Sawai N, Kita M, Kodama T et al. Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun. 1999; 67: 279-85.
23. Shibata J, Goto H, Niwa Y et al. Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut 1999; 45: 24-31.
24. Williamson BD, Carswell EA, Rubin BY, Prendergast JS, Old LJ. Human tumor necrosis factor produced by human B-cell lines: Synergistic cytotoxic interaction with human interferon. Proc. Natl Acad. Sci. 1983; 80: 5397-401.
25. Lee SH, Aggarwal BB, Rinderknecht E, Assisi F, Chiu H. The synergistic anti-proliferative effect of α-interferon and human lymphotoxin. J. Immunol. 1984; 133: 1083-6.
26. Stone-Wolff DS, Yip YK, Kelker HC et al. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin. J. Exp. Med. 1984; 159: 828-43.
27. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Meth. 1995; 184: 39-51.
28. Adayev T, Estephan R, Meserole S, Mazza B, Yurkow EJ, Banerjee P. Externalization of phosphatidylserine may not be an early signal of apoptosis in neuronal cells, but only the phosphatidylserine-displaying apoptosis cells are phagocytosed by microglia. J. Neurochem. 1998; 71: 1854-64.
29. Murphy M, Pike-Nobile L, Soo VW, Epstein LB. Characterization of TNF receptors on human thymocytes. Thymus 1995; 23: 177-94.
30. Douvdevani A, Einbinder T, Yulzari R, Rogachov B, Chaimovitz C. TNF receptors on human peritoneal mesothelial cells. Regulation of receptor levels and shedding by IL-1 α and TNF α. Kidney Int. 1996; 50: 219-28.
31. Wagner S, Beil W, Westermann J et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 1997; 113: 1836-47.
32. Pandita R, Pocsik E, Aggarwal BB. Interferon-γ induced cell surface expression for both types of tumor necrosis factor receptors. FEBS 1992; 312: 87-90.
33. Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon α and tumour necrosis factora on T84 cell function. Gut 1999; 45: 191-8.
34. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 1992; 267: 22506-11.
35. Kim CM, Hong WS, Lee JO et al. Enhancement of cyto-toxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha-beta and -gamma. Jpn. J. Cancer Res. 1989; 80: 904-9.
36. Rochemonteix BG, Nicod LP, Dayer JM. Tumor necrosis factor receptor 75. The principal receptor form by human alveolar macrophage and monocytes in the presence of interferon α. Am. J. Respir. Cell Mol. Biol. 1996; 14: 279-87.
37. Tartaglia LA, Goeddel DV. Two TNF receptors.Immunol. Today 1992; 13: 151-3.